Navigation Links
New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives
Date:6/10/2009

Three-of-Four Patients Surveyed Experience Daily Pain From Rheumatoid Arthritis Despite Current Treatment; Findings Unveiled at the European League Against Rheumatism Annual Congress of Rheumatology

COPENHAGEN, Denmark, June 10 /PRNewswire-FirstCall/ -- Results from the Rheumatoid Arthritis: Insights, Strategies & Expectations (RAISE) survey of more than 500 rheumatoid arthritis (RA) patients throughout Europe and Canada revealed a majority of patients still suffer from pain (79 percent), fatigue (67 percent) and joint stiffness (57 percent) on a regular basis despite current treatment, while more than half (51 percent) of RA patients feel their disease controls their life.

Furthermore, one-third of people with RA surveyed believe nothing can be done to stop the progression of the disease. The survey results were accepted for poster presentation at the 2009 European League Against Rheumatism (EULAR) Annual Congress of Rheumatology in Copenhagen.

The RAISE survey sheds light on the unmet needs of RA patients regarding physician/patient consultation and support, treatment preferences and quality of life issues. Findings from the survey were also premiered at a special roundtable discussion between several of Europe's leading rheumatologists and RA patients representing key advocacy organizations from the United Kingdom, Sweden, Spain, Italy and Germany. The survey was commissioned by Schering-Plough Corporation and conducted by an independent public polling organization.

"Rheumatoid arthritis is a debilitating disease that has a significant impact on a patient's quality of life," said Iain McInnes, MD, PhD, FRCP, Professor of Experimental Medicine and Rheumatology, University of Glasgow, UK and RAISE Patient Needs Panel Steering Group member. "More than half of the surveyed patients feel that their lives are controlled by their rheumatoid arthritis symptoms, demonstrating
'/>"/>

SOURCE Schering-Plough
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
2. International Survey Shows People Over Forty Ignore Risk of Blindness
3. 2007 Global Survey Identifies Characteristics of Supply Chain Leaders
4. Survey Sees Mass. CEOs as Bullish on Own Businesses
5. Boehringer Ingelheim Receives Top Honor as Worlds Most Respected Biopharmaceutical Employer in Science 2007 Top Employers Survey
6. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
7. National Survey Shows Most Women Are Not Satisfied With Their Progesterone Treatment
8. Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
9. The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis
10. Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention
11. Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... and NEW YORK , ... PTBI, PTBIW), a biopharmaceutical company advancing patient care in ... offering of 3,500,000 shares of common stock, and warrants ... common stock, at an offering price of $4.00 per ... per share exercise price of $5.00, are exercisable immediately, ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 Earlier this ... James L. Sherley, director of the Adult Stem Cell ... an often overlooked and under appreciated unique property of ... by Distributed Stem Cells: Misunderstood in the Past, Important ... to congress participants. He gave the address at ...
(Date:12/24/2014)... Nashville, Tenn. (PRWEB) December 23, 2014 ... Hill was elected treasurer for the American Society ... to advancing knowledge and research in reproductive medicine. ... fills a seat on the executive board and will ... , Dr. Hill has actively supported ASRM since ...
(Date:12/24/2014)... December 23, 2014 PharmaBoardroom,s ... out today and available for free download , digs ... change and growth in the sector today. One ... successes has been in developing a homegrown pharmaceutical manufacturing base, ... production still remains some way off. A cursory comparison with ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3
... Mass., March 31 Boston Scientific,Corporation (NYSE: ... Scientific Santa,Rosa Corp., formerly known as TriVascular, Inc., ... in Santa Rosa, California. Boston Scientific,Santa Rosa Corp. ... endovascular aortic repair (EVAR) program. Terms of the ...
... ... Year-over-Year, ALISO VIEJO, Calif., ... and services resource for,pathologists, oncologists and the pharmaceutical industry, today announced,financial ... from continuing operations was $12.4 million for the fourth quarter,of 2007, ...
... poster ... presentations, SOUTH SAN FRANCISCO, Calif., March ... clinical,trials of the company,s investigational compounds XL647, XL184, XL765 and,XL880 will be ... will be held from May 30 to June 3, 2008 in,Chicago, Illinois. ...
Cached Biology Technology:Boston Scientific Announces Sale of TriVascular Endovascular Aortic Repair Program 2Boston Scientific Announces Sale of TriVascular Endovascular Aortic Repair Program 3Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 2Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 3Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 4Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 5Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 6Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 7Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 8Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 9Seven Abstracts Featuring Exelixis Compounds Accepted for Presentation at 2008 ASCO Annual Meeting 2
(Date:12/17/2014)... 15, 2014  HITLAB SM announced today ... audit to confirm its adherence to current U.S. ... enables HITLAB to conduct regulated smart device and ... for patient safety and research quality. ... quality, and delivery with innovative technology," said ...
(Date:12/17/2014)... DUBLIN , Dec. 16, 2014 Research ... announced the addition of the "Global Chemical ... http://photos.prnewswire.com/prnh/20130307/600769 ... is the increasing demand for medical sensors in ... patient data for quick and correct diagnosis during ...
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) ... Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used ... measures the overall facial feature of a person ... distance between eyes. Facial recognition is used for ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... RIVERSIDE, Calif. Julia Bailey-Serres , a geneticist whose ... will give a free, public lecture at UC Riverside on ... challenge of improving crop yield in the face of climate ... Solutions," the hour-long lecture will begin at 7 p.m. in ...
... This press release is available in Spanish . ... calves has been developed by Agricultural Research Service (ARS) scientists who ... nutrient the young animals need to promote optimal growth and health. ... from their mothers as they nurse during the first few days ...
... discovered a defect in cellular pathways that provides a new ... newborns, known as craniosynostosis. Mutations of the WNT ... that regulate bone formation at the stem cell level, according ... Science Signaling . "Our work contributes to the ...
Cached Biology News:Public lecture to explore solutions to the food challenge 2Public lecture to explore solutions to the food challenge 3Model developed for manipulating vitamin D levels in calves 2Stem-cell disruption induces skull deformity, UR study shows 2
Mouse monoclonal [RL13] to LAP1 ( Abpromise for all tested applications). SwissProtID: Q96NW7...
CircuLex Anti-Human S100P Polyclonal Antibody Research Focus: proliferation Storage: -20C Shipping Temperature: 4C...
Mouse monoclonal [7E10] to C Peptide ( Abpromise for all tested applications). entrezGeneID: 3630 SwissProtID: P01308...
Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide...
Biology Products: